Skip to main content
Equibles

LMR Partners LLP

Position in RNA — Atrium Therapeutics, Inc.

CIK 1578621 LONDON, X0
Back to RNA Full portfolio

Position in RNA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$437,125
+$2,600 QoQ
Shares Held
32,500
0.0% QoQ
Ownership
0.190%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#66
of 154 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RNA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

LMR Partners LLP holds $188,560,243 across 74 Biotechnology names. RNA ranks #44 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ALNY
Alnylam Pharmaceuticals, Inc.
 134,214 $40,402,439
2 DNTH
Dianthus Therapeutics, Inc. /DE/
 223,995 $21,835,032
3 REGN
Regeneron Pharmaceuticals, Inc.
 22,306 $13,908,683
4 TNGX
Tango Therapeutics, Inc.
 347,106 $10,850,533
5 RVMD
Revolution Medicines, Inc.
 5,112,098 $8,521,240
6 ARGX
Argenx SE
 8,200 $7,607,714
7 DFTX
Definium Therapeutics, Inc.
 150,200 $7,065,408
8 NKTR
Nektar Therapeutics
 100,000 $6,981,000

All Filings in RNA

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $437,125 32,500
2026-03-31 $434,525 32,500